Reiner Elsässer

A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy

Anton Buchner, Reiner Elsässer, Peter Bias · Breast Cancer Research and Treatment · 2014 · 36 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Acute and chronic anti-inflammatory properties of [2,2-dimethyl-6-(4- chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid.

Stefan Laufer, S. Tries, Juan Jesús Augustín et al. · PubMed · 1995 · 27 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy

Constantin Volovăț, Oleg Gladkov, Reiner Elsässer et al. · SpringerPlus · 2015 · 23 citations · Full text

Medicine, Oncology, Pharmacology +15

Epoetin Theta in Anaemic Cancer Patients Receiving Platinum‐Based Chemotherapy: A Randomised Controlled Trial

Sergei Tjulandin, Peter Bias, Reiner Elsässer et al. · Archives of Drug Information · 2010 · 21 citations · Full text

Medicine, Oncology, Pharmacology +11

Gastrointestinal tolerance of [2,2-dimethyl-6-(4-chlorophenyl-7-phenyl- 2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid in the rat.

Stefan Laufer, S. Tries, Juan Jesús Augustín et al. · PubMed · 1994 · 19 citations

Medicine, Medicinal Chemistry, Pharmacology +9